Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Edgar Blais

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
JBI Evidence Synthesis|June 18, 2026
Completeness of EMERGE guideline reporting in observational studies of PCSK9 inhibitor medication adherence: a study within a systematic reviewWenfang Zhong, Cheuk Ying Vanessa Li, Amy Hai Yan Chan, et al.
JACC. Advances|April 18, 2026
Adherence to PCSK9 Inhibitors in Clinical Practice: Systematic Review and Meta-Analysis of Observational StudiesJoseph Edgar Blais, Wenfang Zhong, Cheuk Ying Vanessa Li, et al.
British Journal of Clinical Pharmacology|December 4, 2025
Blood pressure effects of SGLT2 inhibitors and GLP-1 receptor agonists: Mechanisms, trial evidence and Real-world dataAndrej Belančić, Yusuf Ziya Sener, Marijana Vučković, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 29, 2023
Antibiotic use in hospitalized patients with COVID-19: a population-based study in Hong KongJoseph Edgar Blais, Weixin Zhang, Yun Lin, et al.
Journal of the American College of Cardiology|September 10, 2025
Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes: An EmulationJoseph Edgar Blais, Vincent Ka Chun Yan, Esther Wai Yin Chan, et al.
Annals of Internal Medicine|December 29, 2025
Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation StudyVincent Ka Chun Yan, Joseph Edgar Blais, John-Michael Gamble, et al.
CNS Drugs|October 3, 2020
Antipsychotics and Risk of Neuroleptic Malignant Syndrome: A Population-Based Cohort and Case-Crossover StudyKim S J Lao, Jiaxi Zhao, Joseph Edgar Blais, et al.
The Lancet Regional Health. Western Pacific|June 15, 2026
Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort studyHaonan He, Junhan Tang, Vincent Ka Chun Yan, et al.
Plos One|December 2, 2021
Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular diseaseStephen Franklin Weng, Ralph Kwame Akyea, Kenneth Kc Man, et al.
BMJ Open|February 5, 2022
Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort studyJessica J P Shami, Jiaxi Zhao, Swathi Pathadka, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
JBI Evidence Synthesis|June 18, 2026
Completeness of EMERGE guideline reporting in observational studies of PCSK9 inhibitor medication adherence: a study within a systematic reviewWenfang Zhong, Cheuk Ying Vanessa Li, Amy Hai Yan Chan, et al.
JACC. Advances|April 18, 2026
Adherence to PCSK9 Inhibitors in Clinical Practice: Systematic Review and Meta-Analysis of Observational StudiesJoseph Edgar Blais, Wenfang Zhong, Cheuk Ying Vanessa Li, et al.
British Journal of Clinical Pharmacology|December 4, 2025
Blood pressure effects of SGLT2 inhibitors and GLP-1 receptor agonists: Mechanisms, trial evidence and Real-world dataAndrej Belančić, Yusuf Ziya Sener, Marijana Vučković, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 29, 2023
Antibiotic use in hospitalized patients with COVID-19: a population-based study in Hong KongJoseph Edgar Blais, Weixin Zhang, Yun Lin, et al.
Journal of the American College of Cardiology|September 10, 2025
Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes: An EmulationJoseph Edgar Blais, Vincent Ka Chun Yan, Esther Wai Yin Chan, et al.
Annals of Internal Medicine|December 29, 2025
Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation StudyVincent Ka Chun Yan, Joseph Edgar Blais, John-Michael Gamble, et al.
CNS Drugs|October 3, 2020
Antipsychotics and Risk of Neuroleptic Malignant Syndrome: A Population-Based Cohort and Case-Crossover StudyKim S J Lao, Jiaxi Zhao, Joseph Edgar Blais, et al.
The Lancet Regional Health. Western Pacific|June 15, 2026
Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort studyHaonan He, Junhan Tang, Vincent Ka Chun Yan, et al.
Plos One|December 2, 2021
Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular diseaseStephen Franklin Weng, Ralph Kwame Akyea, Kenneth Kc Man, et al.
BMJ Open|February 5, 2022
Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort studyJessica J P Shami, Jiaxi Zhao, Swathi Pathadka, et al.
Pageof 2